ZyVersa Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
ZyVersa Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q4 2022 to Q3 2024.
  • ZyVersa Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 988K shares, a 916% increase year-over-year.
  • ZyVersa Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 975K shares, a 96% decline from 2022.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 988K +891K +916% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 835K +784K +1537% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 624K +598K +2291% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 975K +717K +279% Dec 31, 2023 10-K 2024-03-25
Q3 2023 97.3K Sep 30, 2023 10-Q 2024-11-14
Q2 2023 51K Jun 30, 2023 10-Q 2024-08-09
Q1 2023 26.1K Mar 31, 2023 10-Q 2024-05-15
Q4 2022 258K Dec 31, 2022 10-K 2024-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.